Results 1 to 10 of about 16,340 (253)

New frontiers in radioembolization

Therapeutic Advances in Medical Oncology
Radioembolization is a locoregional transarterial therapy that combines radionuclide and micron-sized beads to deliver radiation internally to the target tumors based on the arterial blood flow. While initially developed as a palliative treatment option,
Arian Mansur, Peiman Habibollahi, Adam Fang, Armeen Mahvash, Vahid Etezadi, Robert P. Liddell, Juan C. Camacho, Emil I. Cohen, Nima Kokabi, Aravind Arepally, Christos Georgiades, Nariman Nezami   +11 more
doaj   +4 more sources

Beyond hepatocellular carcinoma and colorectal metastasis: The expanding applications of radioembolization [PDF]

Frontiers in Oncology, 2014
As a relatively safe outpatient procedure, radioembolization can potentially be used to treat any type of tumor within the liver, primary or metastatic. The safety and effectiveness of radioembolization in the treatment of hepatocellular carcinoma (HCC)
Omar eZurkiya, Suvranu eGanguli
doaj   +4 more sources

Optimization of Y-90 Radioembolization Imaging for Post-Treatment Dosimetry on a Long Axial Field-of-View PET/CT Scanner

Diagnostics, 2023
Background: PET imaging after yttrium-90 (Y-90) radioembolization is challenging because of the low positron fraction of Y-90 (32 × 10−6). The resulting low number of events can be compensated by the high sensitivity of long axial field-of-view (LAFOV ...
Pia M. Linder, Wenhong Lan, Nils F. Trautwein, Julia Brosch-Lenz, Sebastian von Beschwitz, Jürgen Kupferschläger, Gerald Reischl, Gerd Grözinger, Helmut Dittmann, Christian la Fougère, Fabian P. Schmidt   +10 more
doaj   +2 more sources

Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?

European Journal of Medical Research, 2022
Background In hepatocellular carcinoma (HCC) patients, intraarterial therapies are regularly employed as a bridge to liver transplantation to prevent tumor progression during waiting time. Objective of this study was to compare HCC recurrence after liver
Tamás Benkö, Julia König, Jens M. Theysohn, Clemens Schotten, Fuat H. Saner, Jürgen Treckmann, Sonia Radunz   +6 more
doaj   +2 more sources

Association Between Discharge Medications and Oncologic Post-Embolization-Syndrome-Related Outcomes. [PDF]

Cancer Med
ABSTRACT Background Post‐embolization syndrome after transarterial chemoembolization (TACE) and Yttrium‐90 radioembolization (TARE) causes significant morbidity. Understanding whether discharge prescriptions influence short‐term outcomes may guide standardized pain‐management strategies.
Li H, Moon J, Sim N, Horný M, Lima N, Konstantinidis M, Iyer D, Benenati S, Gichoya J, Newsome J, Bercu Z.   +10 more
europepmc   +2 more sources

Can non-tumorous liver tissue serve as a reliable reference measure for [18F]FDG-PET-CT after unilobar 90Y glass radioembolization in patients with colorectal liver metastases? [PDF]

EJNMMI Research
Background Effect of radiation on [18F]FDG-uptake in non-tumorous liver tissue after radioembolization is sparsely investigated, despite the liver being the most common reference for assessment of metabolic response (e.g., PET Response Criteria In Solid ...
Li Shen Ho, Manon N. G. J. A. Braat, Guus Bol, Maarten. L. J. Smits, Marnix G. E. H. Lam, Arthur J. A. T. Braat   +5 more
doaj   +2 more sources

Laparoscopic right hepatectomy for hepatocellular carcinoma after sequential yttrium-90 liver radioembolization and liver venous deprivation (with video) [PDF]

Journal of Minimally Invasive Surgery
Laparoscopic right hepatectomy has gained acceptance for major oncologic hepatectomies. Preoperative sequential strategies for induced tumor downsizing and contralateral liver hypertrophy ensure the safety of these major hepatectomies, especially in ...
Pierre De Mathelin, Pietro Addeo
doaj   +2 more sources

Interventional oncology: A primer for clinicians on the role of ablation and embolization for solid tumors. [PDF]

CA Cancer J Clin
Abstract Interventional radiology (IR) is a rapidly evolving medical field that combines advanced imaging with minimally invasive techniques for both diagnosis and treatment. Interventional oncology (IO), a subspecialty of IR, focuses on the minimally invasive, image‐guided intervention for cancer and cancer‐related conditions.
Abdelsalam ME, Ahrar K, Sheth RA, Shah KY, Yevich S, Gurusamy V, Odisio BC, Tam AL, Mahvash A, Habibollahi P.   +9 more
europepmc   +2 more sources

Complications of Radioembolization: Prevention and Management [PDF]

Journal of the Korean Society of Radiology
Radioembolization is a relatively safe procedure, and most adverse effects are part of the post-embolization syndrome, which includes symptoms such as abdominal pain and fatigue.
Gyoung Min Kim
doaj   +2 more sources

Radioembolization: Technical Tips and Follow-Up Imaging [PDF]

Journal of the Korean Society of Radiology
Transarterial radioembolization (TARE) is a minimally invasive treatment modality for hepatocellular carcinoma (HCC) that delivers targeted radiation via radioactive microspheres.
Hyo-Cheol Kim
doaj   +2 more sources